GovChime
Notice ID: fbb79d5dd498413eb2c4cd87a5e60988Combined Synopsis/Solicitation

Pharmaceutics Formulation/Chemistry Manufacturing and Controls Consulting Services for Small Molecules and/or Biologics

Archived on August 9, 2022. Original response deadline: . Full description on SAM.gov.

Overview

Response deadline
5:00 PM UTC−04:00
Posted
July 15, 2022
Notice type
Combined Synopsis/Solicitation
Set-aside
Small Business Set Aside - Total
NAICS
541990: All Other Professional, Scientific, and Technical Services
Agency
Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH

Notice details

Office
NATIONAL INSTITUTES OF HEALTH NIDA
Last updated
Sep 25, 2026

Identifiers

Solicitation number
75N95022Q00393
Notice ID
fbb79d5dd498413eb2c4cd87a5e60988

Description

The National Institute of Neurological Disorders and Stroke (NINDS) requires consulting services from senior scientific level, industry-experienced drug discovery and development consultants with expertise in Pharmaceutics Formulation/Chemistry Manufacturing and Controls (CMC) Consulting Services for Small Molecules and/or Biologics, to provide technical guidance to the National Institutes of Health’s (NIH) Blueprint Neurotherapeutics Network (BPN) program and to other NIH, neuroscience-focused drug discovery and development programs. These consulting services are needed on a part-time basis; the number of hours will vary depending on the needs, quality and complexity of an assigned project. The NIH estimates that up to four (4), part-time consultants will be required during the base period of performance and the required level of effort will be 20 to 800 hours per consultant per year. Please see Attachment 1. Statement of Work for details and specifications.

Full description on SAM.gov

Award Overview

No prior contract identified

No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.

Contacts

Contracting Officer

Primary Contact

Secondary Contact

Documents

No documents available.

Lifecycle

Solicitation:75N95022Q00393
  1. Combined Synopsis
  1. 2×
    Combined SynopsisCurrentJul 14, 2022

    Pharmaceutics Formulation/Chemistry Manufacturing and Controls Consulting Services for Small Molecules and/or Biologics

    Notice fbb79d5dd498413eb2c4cd87a5e60988 on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline

Additional Details

Solicitation Number

75N95022Q00393

Archive Date

Aug 9, 2022

Office Address

Bethesda, MD, 20892